Literature DB >> 27059958

Structural Determinants of Binding the Seven-transmembrane Domain of the Glucagon-like Peptide-1 Receptor (GLP-1R).

Dehua Yang1, Chris de Graaf2, Linlin Yang3, Gaojie Song4, Antao Dai1, Xiaoqing Cai1, Yang Feng1, Steffen Reedtz-Runge5, Michael A Hanson6, Huaiyu Yang3, Hualiang Jiang3, Raymond C Stevens7, Ming-Wei Wang8.   

Abstract

The glucagon-like peptide-1 receptor (GLP-1R) belongs to the secretin-like (class B) family of G protein-coupled receptors. Members of the class B family are distinguished by their large extracellular domain, which works cooperatively with the canonical seven-transmembrane (7TM) helical domain to signal in response to binding of various peptide hormones. We have combined structure-based site-specific mutational studies with molecular dynamics simulations of a full-length model of GLP-1R bound to multiple peptide ligand variants. Despite the high sequence similarity between GLP-1R and its closest structural homologue, the glucagon receptor (GCGR), nearly half of the 62 stably expressed mutants affected GLP-1R in a different manner than the corresponding mutants in GCGR. The molecular dynamics simulations of wild-type and mutant GLP-1R·ligand complexes provided molecular insights into GLP-1R-specific recognition mechanisms for the N terminus of GLP-1 by residues in the 7TM pocket and explained how glucagon-mimicking GLP-1 mutants restored binding affinity for (GCGR-mimicking) GLP-1R mutants. Structural analysis of the simulations suggested that peptide ligand binding mode variations in the 7TM binding pocket are facilitated by movement of the extracellular domain relative to the 7TM bundle. These differences in binding modes may account for the pharmacological differences between GLP-1 peptide variants.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  G protein-coupled receptor (GPCR); glucagon; molecular dynamics; peptide interaction; site-directed mutagenesis

Mesh:

Substances:

Year:  2016        PMID: 27059958      PMCID: PMC4933217          DOI: 10.1074/jbc.M116.721977

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

Review 1.  Passing the baton in class B GPCRs: peptide hormone activation via helix induction?

Authors:  Christoph Parthier; Steffen Reedtz-Runge; Rainer Rudolph; Milton T Stubbs
Journal:  Trends Biochem Sci       Date:  2009-05-14       Impact factor: 13.807

2.  Refinement of glucagon-like peptide 1 docking to its intact receptor using mid-region photolabile probes and molecular modeling.

Authors:  Laurence J Miller; Quan Chen; Polo C-H Lam; Delia I Pinon; Patrick M Sexton; Ruben Abagyan; Maoqing Dong
Journal:  J Biol Chem       Date:  2011-03-16       Impact factor: 5.157

3.  Spatial approximations between residues 6 and 12 in the amino-terminal region of glucagon-like peptide 1 and its receptor: a region critical for biological activity.

Authors:  Quan Chen; Delia I Pinon; Laurence J Miller; Maoqing Dong
Journal:  J Biol Chem       Date:  2010-06-07       Impact factor: 5.157

Review 4.  Insights into the structure of class B GPCRs.

Authors:  Kaspar Hollenstein; Chris de Graaf; Andrea Bortolato; Ming-Wei Wang; Fiona H Marshall; Raymond C Stevens
Journal:  Trends Pharmacol Sci       Date:  2013-12-18       Impact factor: 14.819

5.  Residues within the transmembrane domain of the glucagon-like peptide-1 receptor involved in ligand binding and receptor activation: modelling the ligand-bound receptor.

Authors:  K Coopman; R Wallis; G Robb; A J H Brown; G F Wilkinson; D Timms; G B Willars
Journal:  Mol Endocrinol       Date:  2011-08-25

6.  Synthetic competitive antagonists of corticotropin-releasing factor: effect on ACTH secretion in the rat.

Authors:  J Rivier; C Rivier; W Vale
Journal:  Science       Date:  1984-05-25       Impact factor: 47.728

7.  Spatial proximity between the VPAC1 receptor and the amino terminus of agonist and antagonist peptides reveals distinct sites of interaction.

Authors:  Emilie Ceraudo; Régine Hierso; Yossan-Var Tan; Samuel Murail; Christiane Rouyer-Fessard; Pascal Nicole; Jean-Claude Robert; Nadège Jamin; Jean-Michel Neumann; Patrick Robberecht; Marc Laburthe; Alain Couvineau
Journal:  FASEB J       Date:  2012-01-30       Impact factor: 5.191

8.  Scanning of the glucagon-like peptide-1 receptor localizes G protein-activating determinants primarily to the N terminus of the third intracellular loop.

Authors:  S K Mathi; Y Chan; X Li; M B Wheeler
Journal:  Mol Endocrinol       Date:  1997-04

9.  Mutations of aromatic residues in the first transmembrane helix impair signalling by the secretin receptor.

Authors:  E Di Paolo; H Petry; N Moguilevsky; A Bollen; P De Neef; M Waelbroeck; P Robberecht
Journal:  Receptors Channels       Date:  1999

10.  The peptide agonist-binding site of the glucagon-like peptide-1 (GLP-1) receptor based on site-directed mutagenesis and knowledge-based modelling.

Authors:  Rachel L Dods; Dan Donnelly
Journal:  Biosci Rep       Date:  2015-11-23       Impact factor: 3.840

View more
  19 in total

Review 1.  Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes.

Authors:  Chris de Graaf; Dan Donnelly; Denise Wootten; Jesper Lau; Patrick M Sexton; Laurence J Miller; Jung-Mo Ahn; Jiayu Liao; Madeleine M Fletcher; Dehua Yang; Alastair J H Brown; Caihong Zhou; Jiejie Deng; Ming-Wei Wang
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

2.  Structure of the glucagon receptor in complex with a glucagon analogue.

Authors:  Haonan Zhang; Anna Qiao; Linlin Yang; Ned Van Eps; Klaus S Frederiksen; Dehua Yang; Antao Dai; Xiaoqing Cai; Hui Zhang; Cuiying Yi; Can Cao; Lingli He; Huaiyu Yang; Jesper Lau; Oliver P Ernst; Michael A Hanson; Raymond C Stevens; Ming-Wei Wang; Steffen Reedtz-Runge; Hualiang Jiang; Qiang Zhao; Beili Wu
Journal:  Nature       Date:  2018-01-03       Impact factor: 49.962

3.  Thioamide Substitution Selectively Modulates Proteolysis and Receptor Activity of Therapeutic Peptide Hormones.

Authors:  Xing Chen; Elizabeth G Mietlicki-Baase; Taylor M Barrett; Lauren E McGrath; Kieran Koch-Laskowski; John J Ferrie; Matthew R Hayes; E James Petersson
Journal:  J Am Chem Soc       Date:  2017-11-13       Impact factor: 15.419

4.  Phase-plate cryo-EM structure of a biased agonist-bound human GLP-1 receptor-Gs complex.

Authors:  Yi-Lynn Liang; Maryam Khoshouei; Alisa Glukhova; Sebastian G B Furness; Peishen Zhao; Lachlan Clydesdale; Cassandra Koole; Tin T Truong; David M Thal; Saifei Lei; Mazdak Radjainia; Radostin Danev; Wolfgang Baumeister; Ming-Wei Wang; Laurence J Miller; Arthur Christopoulos; Patrick M Sexton; Denise Wootten
Journal:  Nature       Date:  2018-02-21       Impact factor: 49.962

5.  Effects of site-directed mutagenesis of GLP-1 and glucagon receptors on signal transduction activated by dual and triple agonists.

Authors:  Sanaz Darbalaei; Ru-Lue Chang; Qing-Tong Zhou; Yan Chen; An-Tao Dai; Ming-Wei Wang; De-Hua Yang
Journal:  Acta Pharmacol Sin       Date:  2022-08-11       Impact factor: 7.169

6.  Structural and functional diversity among agonist-bound states of the GLP-1 receptor.

Authors:  Brian P Cary; Giuseppe Deganutti; Peishen Zhao; Tin T Truong; Sarah J Piper; Xinyu Liu; Matthew J Belousoff; Radostin Danev; Patrick M Sexton; Denise Wootten; Samuel H Gellman
Journal:  Nat Chem Biol       Date:  2021-12-22       Impact factor: 16.174

7.  Human GLP-1 receptor transmembrane domain structure in complex with allosteric modulators.

Authors:  Gaojie Song; Dehua Yang; Yuxia Wang; Chris de Graaf; Qingtong Zhou; Shanshan Jiang; Kaiwen Liu; Xiaoqing Cai; Antao Dai; Guangyao Lin; Dongsheng Liu; Fan Wu; Yiran Wu; Suwen Zhao; Li Ye; Gye Won Han; Jesper Lau; Beili Wu; Michael A Hanson; Zhi-Jie Liu; Ming-Wei Wang; Raymond C Stevens
Journal:  Nature       Date:  2017-05-17       Impact factor: 49.962

8.  Crystal structure of the GLP-1 receptor bound to a peptide agonist.

Authors:  Ali Jazayeri; Mathieu Rappas; Alastair J H Brown; James Kean; James C Errey; Nathan J Robertson; Cédric Fiez-Vandal; Stephen P Andrews; Miles Congreve; Andrea Bortolato; Jonathan S Mason; Asma H Baig; Iryna Teobald; Andrew S Doré; Malcolm Weir; Robert M Cooke; Fiona H Marshall
Journal:  Nature       Date:  2017-05-31       Impact factor: 49.962

9.  GLP-1 Val8: A Biased GLP-1R Agonist with Altered Binding Kinetics and Impaired Release of Pancreatic Hormones in Rats.

Authors:  Wijnand J C van der Velden; Florent X Smit; Charlotte B Christiansen; Thor C Møller; Gertrud M Hjortø; Olav Larsen; Sine P Schiellerup; Hans Bräuner-Osborne; Jens J Holst; Bolette Hartmann; Thomas M Frimurer; Mette M Rosenkilde
Journal:  ACS Pharmacol Transl Sci       Date:  2021-01-19

10.  Polypharmacy through Phage Display: Selection of Glucagon and GLP-1 Receptor Co-agonists from a Phage-Displayed Peptide Library.

Authors:  Anna Demartis; Armin Lahm; Licia Tomei; Elisa Beghetto; Valentina Di Biasio; Federica Orvieto; Francesco Frattolillo; Paul E Carrington; Sheena Mumick; Brian Hawes; Elisabetta Bianchi; Anandan Palani; Antonello Pessi
Journal:  Sci Rep       Date:  2018-01-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.